Cargando…

Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study

BACKGROUND: To compare treatment modalities: Open flap debridement (OFD) alone (Group I), OFD in combination with PerioGlas(®) (Group II), and OFD in combination with autologous platelet-rich fibrin (PRF) (Group III) for periodontal intrabony defects (IBDs). AIM: To evaluate on clinical and radiogra...

Descripción completa

Detalles Bibliográficos
Autores principales: Yajamanya, Shravanthi Raghav, Chatterjee, Anirban, Hussain, Ahad, Coutinho, Amita, Das, Sushma, Subbaiah, Shobha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767987/
https://www.ncbi.nlm.nih.gov/pubmed/29386798
http://dx.doi.org/10.4103/0972-124X.201628
_version_ 1783292627938967552
author Yajamanya, Shravanthi Raghav
Chatterjee, Anirban
Hussain, Ahad
Coutinho, Amita
Das, Sushma
Subbaiah, Shobha
author_facet Yajamanya, Shravanthi Raghav
Chatterjee, Anirban
Hussain, Ahad
Coutinho, Amita
Das, Sushma
Subbaiah, Shobha
author_sort Yajamanya, Shravanthi Raghav
collection PubMed
description BACKGROUND: To compare treatment modalities: Open flap debridement (OFD) alone (Group I), OFD in combination with PerioGlas(®) (Group II), and OFD in combination with autologous platelet-rich fibrin (PRF) (Group III) for periodontal intrabony defects (IBDs). AIM: To evaluate on clinical and radiographic basis, effectiveness of PerioGlas(®), and PRF in treating IBDs. SETTINGS AND DESIGN: IBDs selected on the basis of the inclusion criteria were randomly assigned to Groups I, II, and III by coin toss method. MATERIALS AND METHODS: The study was conducted on patients reporting to the department of periodontology and oral implantology. Thirty-eight patients with ninety periodontal IBDs of moderate to severe periodontitis were selected and assigned to Groups I, II, and III. In each patient, a minimum number of two sextants were present with pocket depths ≥5 mm in at least three teeth. STATISTICAL ANALYSIS: Statistical analysis based on mean values, standard deviation, and P values. RESULTS: Compared to baseline, 9 months postoperatively: (1) mean probing pocket depth reduction for Group I was 3.68 mm ± 0.72, for Group II was 5.57 mm ± 1.10, and for Group III was 6.11 mm ± 0.92. (2) The mean relative attachment level gain for Group I was 4.14 mm ± 0.76, for Group II was 6.57 mm ± 1.45, and for Group III was 6.74 mm ± 1.55. (3) Mean radiographic IBD fill for Group I was 69.29% mm ± 7.73, for Group II was 74.44% mm ± 8.57, and for Group III was 75.01% mm ± 7.85. CONCLUSION: This study shows marked improvements in the clinical parameters and radiographic outcomes with both PerioGlas(®) and autologous PRF to treat periodontal IBDs as compared to OFD alone.
format Online
Article
Text
id pubmed-5767987
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-57679872018-01-31 Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study Yajamanya, Shravanthi Raghav Chatterjee, Anirban Hussain, Ahad Coutinho, Amita Das, Sushma Subbaiah, Shobha J Indian Soc Periodontol Original Article BACKGROUND: To compare treatment modalities: Open flap debridement (OFD) alone (Group I), OFD in combination with PerioGlas(®) (Group II), and OFD in combination with autologous platelet-rich fibrin (PRF) (Group III) for periodontal intrabony defects (IBDs). AIM: To evaluate on clinical and radiographic basis, effectiveness of PerioGlas(®), and PRF in treating IBDs. SETTINGS AND DESIGN: IBDs selected on the basis of the inclusion criteria were randomly assigned to Groups I, II, and III by coin toss method. MATERIALS AND METHODS: The study was conducted on patients reporting to the department of periodontology and oral implantology. Thirty-eight patients with ninety periodontal IBDs of moderate to severe periodontitis were selected and assigned to Groups I, II, and III. In each patient, a minimum number of two sextants were present with pocket depths ≥5 mm in at least three teeth. STATISTICAL ANALYSIS: Statistical analysis based on mean values, standard deviation, and P values. RESULTS: Compared to baseline, 9 months postoperatively: (1) mean probing pocket depth reduction for Group I was 3.68 mm ± 0.72, for Group II was 5.57 mm ± 1.10, and for Group III was 6.11 mm ± 0.92. (2) The mean relative attachment level gain for Group I was 4.14 mm ± 0.76, for Group II was 6.57 mm ± 1.45, and for Group III was 6.74 mm ± 1.55. (3) Mean radiographic IBD fill for Group I was 69.29% mm ± 7.73, for Group II was 74.44% mm ± 8.57, and for Group III was 75.01% mm ± 7.85. CONCLUSION: This study shows marked improvements in the clinical parameters and radiographic outcomes with both PerioGlas(®) and autologous PRF to treat periodontal IBDs as compared to OFD alone. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5767987/ /pubmed/29386798 http://dx.doi.org/10.4103/0972-124X.201628 Text en Copyright: © 2017 Journal of Indian Society of Periodontology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Yajamanya, Shravanthi Raghav
Chatterjee, Anirban
Hussain, Ahad
Coutinho, Amita
Das, Sushma
Subbaiah, Shobha
Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
title Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
title_full Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
title_fullStr Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
title_full_unstemmed Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
title_short Bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: A comparative clinical study
title_sort bioactive glass versus autologous platelet-rich fibrin for treating periodontal intrabony defects: a comparative clinical study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767987/
https://www.ncbi.nlm.nih.gov/pubmed/29386798
http://dx.doi.org/10.4103/0972-124X.201628
work_keys_str_mv AT yajamanyashravanthiraghav bioactiveglassversusautologousplateletrichfibrinfortreatingperiodontalintrabonydefectsacomparativeclinicalstudy
AT chatterjeeanirban bioactiveglassversusautologousplateletrichfibrinfortreatingperiodontalintrabonydefectsacomparativeclinicalstudy
AT hussainahad bioactiveglassversusautologousplateletrichfibrinfortreatingperiodontalintrabonydefectsacomparativeclinicalstudy
AT coutinhoamita bioactiveglassversusautologousplateletrichfibrinfortreatingperiodontalintrabonydefectsacomparativeclinicalstudy
AT dassushma bioactiveglassversusautologousplateletrichfibrinfortreatingperiodontalintrabonydefectsacomparativeclinicalstudy
AT subbaiahshobha bioactiveglassversusautologousplateletrichfibrinfortreatingperiodontalintrabonydefectsacomparativeclinicalstudy